Clinical characteristics classified by the serum KL-6 level in patients with organizing pneumonia

Sarcoidosis Vasc Diffuse Lung Dis. 2013 Mar;30(1):43-51.

Abstract

Background: The serum Krebs von der Lungen-6 (KL-6) level is a useful marker correlated with the severity of various interstitial lung diseases. There have been few reports about the clinical characteristics of organizing pneumonia (OP) associated with the serum KL-6 levels.

Objective: This study was performed to determine whether the serum KL-6 levels can help determine the optimal treatment for OP.

Designs: Patients diagnosed with OP by clinical, radiological and histopathological findings were retrospectively reviewed. The OP patients were classified into two groups based on their serum KL-6 levels: normal KL-6 and high KL-6 groups. The two groups were compared with regard to their clinical and radiological data and therapeutic response one month after the start of treatment.

Results: The clinical records of twenty-two patients diagnosed with OP were reviewed. The serum KL-6 level was elevated in 11 of the 22 patients. There were no obvious differences in the clinical data between the two groups, although patients in the normal KL-6 group tended to have a fever. There were no significant differences in the chest X-ray (CXR) score or computed tomography (CT) score between the two groups. The CXR scores were correlated with the serum KL-6 levels. At 1 month after the diagnosis, 11 patients who needed treatment with prednisolone were included in the high KL-6 group.

Conclusions: Patients with normal KL-6 levels showed lower CXR and CT scores. The serum KL-6 level on admission is a useful marker to judge the need for corticosteroid treatment in OP patients.

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Biomarkers / blood*
  • Bronchoscopy
  • Cryptogenic Organizing Pneumonia / blood*
  • Cryptogenic Organizing Pneumonia / diagnosis
  • Cryptogenic Organizing Pneumonia / diagnostic imaging
  • Cryptogenic Organizing Pneumonia / drug therapy
  • Female
  • Humans
  • Male
  • Middle Aged
  • Mucin-1 / blood*
  • Retrospective Studies
  • Tomography, X-Ray Computed

Substances

  • Adrenal Cortex Hormones
  • Biomarkers
  • MUC1 protein, human
  • Mucin-1